FPTW
MRK icon

Franklin, Parlapiano, Turner & Welch’s Merck MRK Stock Holding History

Franklin, Parlapiano, Turner & Welch’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-584
Closed -$35K – 89
2017
Q1 		$35K Hold
584
– – 0.02% 85
2016
Q4 		$33K Buy
+584
New +$34.2K 0.02% 83

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin, Parlapiano, Turner & Welch's MRK Position: Q2 2017 in Review

Franklin, Parlapiano, Turner & Welch sold out of Merck (MRK) in Q2 2017, closing a stake of 584 shares — an estimated $35K sold.

Franklin, Parlapiano, Turner & Welch first reported a position in MRK in Q4 2016 and held it in 2 quarters. The position peaked at $35K in Q1 2017. 1,926 funds tracked by Wall St. Rank hold MRK as of Q2 2017.

  • Franklin, Parlapiano, Turner & Welch reported no remaining Merck position as of Q2 2017 after selling out during the quarter.
  • Franklin, Parlapiano, Turner & Welch sold 584 Merck shares in Q2 2017, an estimated $35K.
  • Franklin, Parlapiano, Turner & Welch first reported a position in Merck in Q4 2016 and held it in 2 quarters.
  • Franklin, Parlapiano, Turner & Welch's Merck position peaked at $35K in Q1 2017.
  • 1,926 funds tracked by Wall St. Rank held Merck as of Q2 2017.

Based on Franklin, Parlapiano, Turner & Welch's 13F filing for Q2 2017, filed 17 Jul 2017.